Biocon Limited — QIP/Rights/Pref., 06-12-2025: Issue of Securities

Biocon is issuing 17.13 Cr equity shares (Rs. 405.78 each) worth Rs. 6,950 Cr to acquire Biocon Biologics shares from key investors. They'll also raise up to Rs. 4,500 Cr for Mylan, plus Rs. 1,800 Cr via Commercial Papers for interim cash. Shareholders meet Dec 31 for approval.